Zeinab AbdulRehman
Department of Medicine, Division of Nephrology and Hypertension, Jersey Shore University Medical Cen, USA
Publications
-
Clinical Review
Clinical Outcomes in Patients Receiving Icodextrin Only for Peritoneal Dialysis vs Dextrose in Peritoneal Dialysis
Author(s): Supreet Kaur, Sushil Mehandru*, Mohammad Zafar, Riya Tandra, Saikiran Mandyam, Eric Aulov, Harry Dounis, Avais Masud and Zeinab AbdulRehman
Peritoneal Dialysis (PD), used for patients with ESRD, can involve 7.5% Icodextrin, dextrose, or a combination. Icodextrinonly PD has been shown to improve sodium removal, blood pressure, glycemic control, and reduce PD failure rates, yet it remains underutilized. This study analyzed outcomes from patients at Davita Home Dialysis Center in Wall Township, NJ, over a 5-year period. We compared clinical outcomes between patients using Icodextrin-only peritoneal dialysis (PD) and those using dextrose-based or combined dextrose-Icodextrin solutions for a minimum of six months. A retrospective review of de-identified patient data (Sept 2019-Jan 2024) compared serum potassium, phosphate, hemoglobin, albumin, residual urine, peritonitis events, and conversion to hemodialysis in patients using Icodextrin-only PD versus dextrose-based or combination solutions. Icodextrin-only PD achieved compar.. Read More»

